Published :
Tables : 45
Figures : 46
Category : Healthcare
No. of Pages : 232
Report Code : HC-U3529
Parenteral Drugs Market Introduction FutureWise Market Research has instantiated a report that provides an intricate analysis of Parenteral Drugs Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Parenteral Drugs Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Parenteral Drugs Market: • Pfizer Inc. • Novartis AG • Teva Pharmaceutical Industries Ltd. • Sanofi S.A. • Sun Pharmaceutical Industries Ltd.Sun Pharmaceutical Industries Ltd. • AstraZeneca Plc • Merck & Co., Inc. • Mylan N.V • Cipla Inc. • Dr. Reddy’s Laboratories Ltd. (Note: The list of the major players will be updated with the latest market scenario and trends) Parenteral Drugs Market Segmentation: By Product Type • Monoclonal Antibodies • Immunoglobulin • Cytokines • Insulin • Peptide Hormones • Blood Factors • Peptide Antibiotics • Vaccines • Small Molecule Antibiotics • Chemotherapy Agents • Others By Application • Oncology • Infectious Diseases • Diabetes • Blood disorders • Hormonal Disorders • Musculoskeletal Disorders • CNS Diseases • Pain Management • Cardiovascular Diseases By Molecule Type • Small Molecules • Large Molecules By Route of Administration • Intravenous (IV) • Intramuscular (IM) • Subcutaneous (SC) By Distribution Channel • Hospital Pharmacies • Retail Pharmacies • Drug Stores • Online Pharmacies By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Parenteral Drugs Market By Product Type, By Application, By Molecule Type, By Route of Administration, By Distribution Channel and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- Product Type launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Parenteral Drugs Market Introduction
FutureWise Market Research has instantiated a report that provides an intricate analysis of Parenteral Drugs Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Parenteral Drugs Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Parenteral Drugs Market: • Pfizer Inc. • Novartis AG • Teva Pharmaceutical Industries Ltd. • Sanofi S.A. • Sun Pharmaceutical Industries Ltd.Sun Pharmaceutical Industries Ltd. • AstraZeneca Plc • Merck & Co., Inc. • Mylan N.V • Cipla Inc. • Dr. Reddy’s Laboratories Ltd. (Note: The list of the major players will be updated with the latest market scenario and trends) Parenteral Drugs Market Segmentation: By Product Type • Monoclonal Antibodies • Immunoglobulin • Cytokines • Insulin • Peptide Hormones • Blood Factors • Peptide Antibiotics • Vaccines • Small Molecule Antibiotics • Chemotherapy Agents • Others
By Application • Oncology • Infectious Diseases • Diabetes • Blood disorders • Hormonal Disorders • Musculoskeletal Disorders • CNS Diseases • Pain Management • Cardiovascular Diseases
By Molecule Type • Small Molecules • Large Molecules
By Route of Administration • Intravenous (IV) • Intramuscular (IM) • Subcutaneous (SC)
By Distribution Channel • Hospital Pharmacies • Retail Pharmacies • Drug Stores • Online Pharmacies
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Parenteral Drugs Market By Product Type, By Application, By Molecule Type, By Route of Administration, By Distribution Channel and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- Product Type launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Parenteral Drugs Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Application Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Parenteral Drugs Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Parenteral Drugs Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Application Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Application Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Parenteral Drugs Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Monoclonal Antibodies 7.2. Immunoglobulin 7.3. Cytokines 7.4. Insulin 7.5. Peptide Hormones 7.6. Blood Factors 7.7. Peptide Antibiotics 7.8. Vaccines 7.9. Small Molecule Antibiotics 7.10. Chemotherapy Agents 7.11. Others 8. Global Parenteral Drugs Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Oncology 8.2. Infectious Diseases 8.3. Diabetes 8.4. Blood disorders 8.5. Hormonal Disorders 8.6. Musculoskeletal Disorders 8.7. CNS Diseases 8.8. Pain Management 8.9. Cardiovascular Diseases 9. Global Parenteral Drugs Market, By Molecule Type Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Small Molecules 9.2. Large Molecules 10. Global Parenteral Drugs Market, By Route of Administration Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Intravenous (IV) 10.2. Intramuscular (IM) 10.3. Subcutaneous (SC) 11. Global Parenteral Drugs Market, By Distribution Channel Historical Analysis and Forecast 2020-2027 (USD Million) 11.1. Hospital Pharmacies 11.2. Retail Pharmacies 11.3. Drug Stores 11.4. Online Pharmacies 12. North America Parenteral Drugs Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2020-2027 13. Latin America Parenteral Drugs Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2020-2027 14. Europe Parenteral Drugs Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2020-2027 15. Asia Pacific Parenteral Drugs Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 16.2.1. Saudi Arabia 16.2.2. UAE 16.2.3. South Africa 16.2.4. Egypt 16.3. Market Size (USD Million) Forecast for MEA 2020-2027 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Types Offered and Financial Layouts) 18.1. Pfizer Inc. 18.1.1. Company Overview 18.1.2. Product Type Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Novartis AG 18.2.1. Company Overview 18.2.2. Product Type Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Teva Pharmaceutical Industries Ltd. 18.3.1. Company Overview 18.3.2. Product Type Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. PathoFinder BV 18.4.1. Company Overview 18.4.2. Product Type Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5 Sun Pharmaceutical Industries Ltd.Sun Pharmaceutical Industries Ltd. 18.5.1. Company Overview 18.5.2. Product Type Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6 AstraZeneca Plc 18.6.1. Company Overview 18.6.2. Product Type Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Merck & Co., Inc. 18.7.1. Company Overview 18.7.2. Product Type Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Mylan N.V 18.8.1. Company Overview 18.8.2. Product Type Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Cipla Inc. 18.9.1. Company Overview 18.9.2. Product Type Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10. Dr. Reddy’s Laboratories Ltd. 18.10.1.Company Overview 18.10.2.Product Type Portfolio 18.10.3.SWOT Analysis 18.10.4.Financial Overview 18.10.5.Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics